283 related articles for article (PubMed ID: 31932920)
21. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
[TBL] [Abstract][Full Text] [Related]
22. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
23. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
24. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
26. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
Mikami Y; McCluggage WG
Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
[TBL] [Abstract][Full Text] [Related]
27. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
28. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses.
Kondo T; Hashi A; Murata S; Nakazawa T; Yuminamochi T; Nara M; Hoshi K; Katoh R
Mod Pathol; 2005 Sep; 18(9):1199-210. PubMed ID: 15761489
[TBL] [Abstract][Full Text] [Related]
29. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix.
Kojima A; Mikami Y; Sudo T; Yamaguchi S; Kusanagi Y; Ito M; Nishimura R
Am J Surg Pathol; 2007 May; 31(5):664-72. PubMed ID: 17460448
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia.
Ota H; Harada O; Uehara T; Hayama M; Ishii K
Am J Clin Pathol; 2011 Feb; 135(2):253-61. PubMed ID: 21228366
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
32. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
33. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
34. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
35. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection.
Nara M; Hashi A; Murata S; Kondo T; Yuminamochi T; Nakazawa K; Katoh R; Hoshi K
Gynecol Oncol; 2007 Aug; 106(2):289-98. PubMed ID: 17540439
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
Mikami Y; Kiyokawa T; Moriya T; Sasano H
Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
[TBL] [Abstract][Full Text] [Related]
37. Cytomorphologic Features of Gastric-Type Endocervical Adenocarcinoma in Liquid-Based Preparations.
Schwock J; Starova B; Khan ZF; Mirkovic J; Parra-Herran C; Ko HM; Rouzbahman M; Ghorab Z
Acta Cytol; 2021; 65(1):56-66. PubMed ID: 33152741
[TBL] [Abstract][Full Text] [Related]
38. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist?
Goldstein NS; Ahmad E; Hussain M; Hankin RC; Perez-Reyes N
Am J Clin Pathol; 1998 Aug; 110(2):200-9. PubMed ID: 9704619
[TBL] [Abstract][Full Text] [Related]
39. Gastric-type mucinous carcinoma of the cervix and its precursors - historical overview.
Mikami Y
Histopathology; 2020 Jan; 76(1):102-111. PubMed ID: 31846534
[TBL] [Abstract][Full Text] [Related]
40. Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases.
Lu S; Shen D; Zhao Y; Kang N; Wang X
Diagn Pathol; 2019 Jul; 14(1):72. PubMed ID: 31279344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
